Genomas
Hartford
About Genomas
Genomas® is a biomedical company bringing DNA-Guided medicine to clinical practice with products for personalized prescription of drugs used in the treatment of mental illness, diabetes, and cardiovascular disease (CVD). Our products eliminate trial-and-error prescription with DNA-Guided medicine and enable physicians to treat with unprecedented precision, avoiding significant drug side effects, improving efficacy and enhancing patient compliance. Core applications are drug treatments of mood and thought disorders in mental illness and of cardiometabolic risk in diabetes and CVD. The products are developed in partnership with 3 leading Connecticut medical institutions, Hartford Hospital, The Institute of Living and Hospital of Central CT and with the University of Puerto Rico Medical Sciences.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.0M
- Funding stage: M&A
- Last round: Debt Financing (Apr 2009)
- Website: genomas.net
- Phone: (860)545-4574
Industries & Categories
Biotechnology, Diabetes, Health Care
Canonical: https://fsome.com/organization/genomas-3162288 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.